Effects of levonorgestrel-releasing subdermal contraceptive implants on bone density and bone metabolism
- 1 September 1999
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 60 (3) , 161-166
- https://doi.org/10.1016/s0010-7824(99)00080-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patientsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1999
- Bone density among long-term users of medroxyprogesterone acetate as a contraceptiveContraception, 1998
- Norplant® Consensus Statement and Background ReviewContraception, 1998
- Biochemical aspects of hormonal contraception: Effects on bone metabolismThe European Journal of Contraception & Reproductive Health Care, 1997
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- Differential effects on bone density of progestogen-only methods for contraception in premenopausal womenContraception, 1995
- Bone mass and long-term monophasic oral contraceptive treatment in young womenContraception, 1995
- Oral progestogen‐only contraception may protect against loss of bone mass in breast‐feeding womenClinical Endocrinology, 1994
- Pathogenesis, Prevention, and Treatment of OsteoporosisObstetrics & Gynecology, 1990
- Changes in Physiologically Free Circulating Estradiol and Testosterone during Exposure to Levonorgestrel*Journal of Clinical Endocrinology & Metabolism, 1981